Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pulmonary Hypertension Associated With Trastuzumab-Emtansine: An Analysis of French PH Registry and WHO Pharmacovigilance Database.
Poisson C, Hlavaty A, Favrolt N, Chaumais MC, Grynblat J, Jutant EM, Lechartier B, Maurac A, Mouillot P, Palat S, Rambach L, Antigny F, Cottin V, Beltramo G, Humbert M, Khouri C, Bonniaud P, Montani D. Poisson C, et al. Among authors: grynblat j. Chest. 2024 Nov 19:S0012-3692(24)05562-4. doi: 10.1016/j.chest.2024.11.006. Online ahead of print. Chest. 2024. PMID: 39571726 Free article.
Pulmonary hypertension in patients carrying FLNA loss-of-function variants.
Stourm L, Grynblat J, Savale L, Lacoste-Palasset T, Jaïs X, Coulet F, Levy M, Meyrignac O, Ghigna MR, Cottin V, Sitbon O, Bonnet D, Goupil F, Humbert M, Gagnadoux F, Montani D; French PH Network PULMOTENSION Investigators. Stourm L, et al. Among authors: grynblat j. Eur Respir J. 2024 Nov 7:2401132. doi: 10.1183/13993003.01132-2024. Online ahead of print. Eur Respir J. 2024. PMID: 39510553
Deep phenotyping of unaffected carriers of pathogenic BMPR2 variants screened for pulmonary arterial hypertension.
Tóth EN, Celant LR, Niglas M, Jansen S, Tramper J, Baxan N, Ashek A, Wessels JN, Marcus JT, Meijboom LJ, Houweling AC, Nossent EJ, Aman J, Grynblat J, Perros F, Montani D, Vonk Noordegraaf A, Zhao L, de Man FS, Bogaard HJ. Tóth EN, et al. Among authors: grynblat j. Eur Respir J. 2024 Oct 3;64(4):2400442. doi: 10.1183/13993003.00442-2024. Print 2024 Oct. Eur Respir J. 2024. PMID: 38991711 Free PMC article.
Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation.
Todesco A, Grynblat J, Akoumia KKF, Bonnet D, Mendes-Ferreira P, Morisset S, Chemla D, Levy M, Méot M, Malekzadeh-Milani SG, Tielemans B, Decante B, Vastel-Amzallag C, Habert P, Ghigna MR, Humbert M, Montani D, Boulate D, Perros F. Todesco A, et al. Among authors: grynblat j. J Am Heart Assoc. 2024 Jul 16;13(14):e034621. doi: 10.1161/JAHA.124.034621. Epub 2024 Jul 9. J Am Heart Assoc. 2024. PMID: 38979789 Free PMC article.
Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting.
Boucly A, Bertoletti L, Fauvel C, Dewavrin MG, Gerges C, Grynblat J, Guignabert C, Hascoet S, Jaïs X, Jutant EM, Lamblin N, Meyrignac O, Riou M, Savale L, Tromeur C, Turquier S, Valentin S, Simonneau G, Humbert M, Sitbon O, Montani D; on behalf on the French PH Network. Boucly A, et al. Among authors: grynblat j. Respir Med Res. 2024 Nov;86:101123. doi: 10.1016/j.resmer.2024.101123. Epub 2024 Jun 22. Respir Med Res. 2024. PMID: 38972109 Review.
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness.
Rachedi NS, Tang Y, Tai YY, Zhao J, Chauvet C, Grynblat J, Akoumia KKF, Estephan L, Torrino S, Sbai C, Ait-Mouffok A, Latoche JD, Al Aaraj Y, Brau F, Abélanet S, Clavel S, Zhang Y, Guillermier C, Kumar NVG, Tavakoli S, Mercier O, Risbano MG, Yao ZK, Yang G, Ouerfelli O, Lewis JS, Montani D, Humbert M, Steinhauser ML, Anderson CJ, Oldham WM, Perros F, Bertero T, Chan SY. Rachedi NS, et al. Among authors: grynblat j. Cell Metab. 2024 Jun 4;36(6):1335-1350.e8. doi: 10.1016/j.cmet.2024.04.010. Epub 2024 May 2. Cell Metab. 2024. PMID: 38701775
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
Grynblat J, Khouri C, Hlavaty A, Jaïs X, Savale L, Chaumais MC, Kularatne M, Jevnikar M, Boucly A, Antigny F, Perros F, Simonneau G, Sitbon O, Humbert M, Montani D; and the French PH Network PULMOTENSION Investigators. Grynblat J, et al. Eur Respir J. 2024 Jun 28;63(6):2302158. doi: 10.1183/13993003.02158-2023. Print 2024 Jun. Eur Respir J. 2024. PMID: 38697649
Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre study.
Grynblat J, Bogaard HJ, Eyries M, Meyrignac O, Savale L, Jaïs X, Ghigna MR, Celant L, Meijboom L, Houweling AC, Levy M, Antigny F, Chaouat A, Cottin V, Guignabert C, Coulet F, Sitbon O, Bonnet D, Humbert M, Montani D; and the French PH Network PULMOTENSION Investigators. Grynblat J, et al. Eur Respir J. 2024 Apr 4;63(4):2301634. doi: 10.1183/13993003.01634-2023. Print 2024 Apr. Eur Respir J. 2024. PMID: 38514094 Review.
Pulmonary hypertension associated with diazoxide: the SUR1 paradox.
Montani D, Antigny F, Jutant EM, Chaumais MC, Le Ribeuz H, Grynblat J, Khouri C, Humbert M. Montani D, et al. Among authors: grynblat j. ERJ Open Res. 2023 Nov 13;9(6):00350-2023. doi: 10.1183/23120541.00350-2023. eCollection 2023 Nov. ERJ Open Res. 2023. PMID: 37965230 Free PMC article. Review.
Diagnosis and management of pulmonary veno-occlusive disease.
Solinas S, Boucly A, Beurnier A, Kularatne M, Grynblat J, Eyries M, Dorfmüller P, Sitbon O, Humbert M, Montani D. Solinas S, et al. Among authors: grynblat j. Expert Rev Respir Med. 2023 Jul-Dec;17(8):635-649. doi: 10.1080/17476348.2023.2247989. Epub 2023 Aug 21. Expert Rev Respir Med. 2023. PMID: 37578057 Review.
14 results